KNOWLEDGE HUB

Serving microbiome innovators as the best-in-class CDMO means keeping our fingertips on the pulse of the industry. Discover what's new and what's next in this fast-moving field.

RESOURCES  FROM  ARRANTA

LATEST MICROBIOME INDUSTRY NEWS

JUNE 2021

Dispersal strategies shape persistence and evolution of human gut bacteria – Cell Host & Microbe

Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice - Gut

Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future? – Cell Metabolism

Microbial exposure during early human development primes fetal immune cells – Cell

Design of synthetic human gut microbiome assembly and butyrate production – Nature Communications

MAY 2021

Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis - Nature Communications

Critical evaluation of faecal microbiome preservation using metagenomic analysis – Nature ISME Communications

Host genetics, the microbiome & behaviour—a ‘Holobiont’ perspective – Nature, Cell Research

Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip – Nature Communications

Reconstruction of ancient microbial genomes from the human gut – Nature 

Evaluation of changes in intestinal microbiota in Crohn’s disease patients after anti-TNF alpha treatment – Nature, Scientific Reports

Programming gene expression in multicellular organisms for physiology modulation through engineered bacteria – Nature Communications

Fecal microbiota transplantation: can it circumvent resistance to PD-1 blockade in melanoma?

Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment – Nature, Cell & Death Differentiation

Piles of ancient poop reveal ‘extinction event’ in human gut bacteria – Science Magazine

Microbial exposure during early human development primes fetal immune cells

placeholder

Learn more about Arranta Bio and our commitment to microbiome innovators and the patients they serve by downloading our latest articles with interviews from our SMEs.

visit the arranta bio microbiome industry news archive

Read the latest press releases and news from Arranta Bio.

white paper request

Reserve a copy of our upcoming white paper.

placeholder

Videos, presentations, and interviews with our subject matter experts.

C O N T A C T

Get in Touch

We're always open to engaging with individuals interested in our company or the microbiome therapy market in general. 

We look forward to hearing from you.

Headquarters &
cGMP Manufacturing

650 Pleasant Street
Watertown, MA 02472

Process Development
& cGMP Manufacturing

1622 NW 55th Pl.
Gainesville, FL 32653

For CDMO Service Inquiries: bd@arrantabio.com